María Díez Campelo, MD, PhD

home / authors / mar-a-d-ez-campelo-md-phd

María Díez Campelo, MD, PhD, is a hematologist at the University Hospital of Salamanca.

Articles

July 20th 2025

Quality of Life, Caregiver Impact Key to Future Imetelstat Research in Lower-Risk MDS: María Díez Campelo, MD, PhD

Brooke McCormick María Díez Campelo, MD, PhD

María Díez Campelo, MD, PhD, concludes by highlighting imetelstat’s real-world quality of life benefits for patients with lower-risk myelodysplastic syndromes (MDS) and the need for improved patient-reported outcome tools and caregiver-focused research.

July 17th 2025

Imetelstat Linked to Sustained Health-Related Quality-of-Life Benefits in Lower-Risk MDS: María Díez Campelo, MD, PhD

Brooke McCormick María Díez Campelo, MD, PhD

Imetelstat (Rytelo; Geron) significantly improved and sustained health-related quality of life in patients with lower-risk myelodysplastic syndromes (MDS), with benefits linked directly to the drug rather than patient characteristics.

July 16th 2025

Evaluating Imetelstat's Impact on Health-Related Quality of Life in Lower-Risk MDS: María Díez Campelo, MD, PhD

Brooke McCormick María Díez Campelo, MD, PhD

The phase 3 IMerge trial (NCT02598661) evaluated how treatment with imetelstat impacts health-related quality of life in patients with lower-risk myelodysplastic syndromes (MDS), according to María Díez Campelo, MD, PhD.